Fundraising Fox

Neopenda

Techstars '18

Chicago, US · Delaware corporation · 4 known investors

neopenda.com ↗

Neopenda develops health-technology devices for neonatal care in emerging markets, specifically serving healthcare facilities in underserved populations. The company, structured as a public benefit corporation, focuses on innovative products to improve health outcomes in resource-limited settings.

BiotechFintechHealthtechImpact & Social GoodIoTMedical Devicesin /neopenda@Neopenda_Health

Founders & leadership

SS
Sona ShahCEO and Founder
TC
Teresa CauvelCTO and Founder
ZS
Zachary SeavernsDirector

Investors · 4

Connetic VenturesCovington · $250K – $500K
Founders Factory AfricaJohannesburg
TechstarsBoulder · $220K
Villgro AfricaNairobi

Reported raises · per SEC filings

Form D private placements
▶$35KraisedMay 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zachary SeavernsDirector
  • Teresa CauvelExecutive Officer, Director
  • Sona ShahExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$35K
Minimum investment
$5K
Proceeds to insiders
$150K
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$200KraisedNov 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sona ShahExecutive Officer, Director
  • Teresa CauvelExecutive Officer, Director
  • Zachary SeavernsDirector
Offering amount
$1.5M
Amount sold
$200K
Minimum investment
$5K
Proceeds to insiders
$375K
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$700KraisedJan 2024 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Teresa CauvelExecutive Officer, Director
  • Sona ShahExecutive Officer, Director
  • Zachary SeavernsDirector
Offering amount
$1.5M
Amount sold
$700K
Minimum investment
$10K
Proceeds to insiders
$240K
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$252KraisedJun 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zachary SeavernsDirector
  • Teresa CauvelExecutive Officer, Director
  • Sona ShahExecutive Officer, Director
Offering amount
$1.7M
Amount sold
$252K
Minimum investment
$25K
Proceeds to insiders
$215K
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$410KraisedMar 2019 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sona ShahExecutive Officer, Director
  • Teresa CauvelExecutive Officer, Director
Offering amount
$1.3M
Amount sold
$410K
Proceeds to insiders
$180K
First sale
Feb 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$125KraisedAug 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Teresa CauvelExecutive Officer, Director
  • Sona ShahExecutive Officer, Director
Offering amount
$125K
Amount sold
$125K
Minimum investment
$25K
Proceeds to insiders
$42K
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20KraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sona ShahExecutive Officer, Director
  • Teresa CauvelExecutive Officer, Director
Offering amount
$20K
Amount sold
$20K
Minimum investment
$20K
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news